Share on StockTwits

ADMA Biologics (NASDAQ:ADMA) CEO Adam S. Grossman bought 2,100 shares of the stock on the open market in a transaction dated Thursday, August 14th. The shares were purchased at an average cost of $9.77 per share, for a total transaction of $20,517.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of ADMA Biologics (NASDAQ:ADMA) traded up 0.21% on Friday, hitting $9.77. The stock had a trading volume of 10,620 shares. ADMA Biologics has a 52-week low of $6.52 and a 52-week high of $10.75. The stock’s 50-day moving average is $9.9 and its 200-day moving average is $8.82. The company’s market cap is $90.8 million.

Separately, analysts at Maxim Group reiterated a “buy” rating on shares of ADMA Biologics in a research note on Friday, July 11th. They now have a $15.00 price target on the stock.

Receive News & Ratings for ADMA Biologics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADMA Biologics Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.